166 related articles for article (PubMed ID: 37821555)
1. Characteristics and risk of interstitial lung disease in dermatomyositis and polymyositis: a retrospective cohort study in Japan.
Hu Q; Huang KC; Goh CH; Tsuchiya Y; Liu Y; Qiu H
Sci Rep; 2023 Oct; 13(1):17172. PubMed ID: 37821555
[TBL] [Abstract][Full Text] [Related]
2. Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial.
Takada K; Katada Y; Ito S; Hayashi T; Kishi J; Itoh K; Yamashita H; Hirakata M; Kawahata K; Kawakami A; Watanabe N; Atsumi T; Takasaki Y; Miyasaka N
Rheumatology (Oxford); 2020 May; 59(5):1084-1093. PubMed ID: 31539061
[TBL] [Abstract][Full Text] [Related]
3. Predicting factors of interstitial lung disease in dermatomyositis and polymyositis.
Chen YJ; Wu CY; Shen JL
Acta Derm Venereol; 2007; 87(1):33-8. PubMed ID: 17225013
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Risk Factors of Polymyositis and Dermatomyositis Combined with Interstitial Lung Disease in Patients Residing in the Northeast Sichuan Province of China.
Li T; Tang ZY; Zhang QB; Xiao FN; Jian GL; Xie Y; Guo JW; Qing YF
Curr Rheumatol Rev; 2023; 19(4):455-462. PubMed ID: 37005523
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
Hozumi H; Fujisawa T; Nakashima R; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Inui N; Nakamura Y; Mimori T; Suda T
J Rheumatol; 2019 May; 46(5):509-517. PubMed ID: 30647164
[TBL] [Abstract][Full Text] [Related]
6. Interstitial lung disease in polymyositis and dermatomyositis.
Fathi M; Lundberg IE
Curr Opin Rheumatol; 2005 Nov; 17(6):701-6. PubMed ID: 16224246
[TBL] [Abstract][Full Text] [Related]
7. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis.
Azuma K; Yamada H; Ohkubo M; Yamasaki Y; Yamasaki M; Mizushima M; Ozaki S
Mod Rheumatol; 2011 Apr; 21(2):178-83. PubMed ID: 20922453
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study.
Motomura K; Yamashita H; Yamada S; Takahashi Y; Kaneko H
Rheumatol Int; 2019 Oct; 39(10):1733-1739. PubMed ID: 31444556
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan.
Kuwana M; Wakasugi N; Furuya T; Uno S; Suda T
J Rheumatol; 2022 Jul; 49(7):707-718. PubMed ID: 35428708
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary damage during polymyositis and dermatomyositis: interstitial lung disease].
Marie I; Dominique S
Presse Med; 2006 Apr; 35(4 Pt 2):683-95. PubMed ID: 16614615
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
So MW; Koo BS; Kim YG; Lee CK; Yoo B
J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.
Kurita T; Yasuda S; Oba K; Odani T; Kono M; Otomo K; Fujieda Y; Oku K; Bohgaki T; Amengual O; Horita T; Atsumi T
Rheumatology (Oxford); 2015 Jan; 54(1):39-44. PubMed ID: 24764266
[TBL] [Abstract][Full Text] [Related]
13. [Interstitial lung disease in polymyositis/dermatomyositis].
Schnabel A
Z Rheumatol; 2013 Apr; 72(3):220-6. PubMed ID: 23553021
[TBL] [Abstract][Full Text] [Related]
14. KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis.
Fathi M; Barbasso Helmers S; Lundberg IE
J Intern Med; 2012 Jun; 271(6):589-97. PubMed ID: 21950266
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis.
Palmucci S; Di Mari A; Cancemi G; Pennisi I; Mauro LA; Sambataro G; Sambataro D; Galioto F; Fazio G; Ferlito A; Pino F; Basile A; Vancheri C
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556960
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study.
Chung WS; Lin CL; Sung FC; Lu CC; Kao CH
Thromb Res; 2014 Sep; 134(3):622-6. PubMed ID: 25034321
[TBL] [Abstract][Full Text] [Related]
17. The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease.
Sugiyama Y; Yoshimi R; Tamura M; Takeno M; Kunishita Y; Kishimoto D; Yoshioka Y; Kobayashi K; Takase-Minegishi K; Watanabe T; Hamada N; Nagai H; Tsuchida N; Soejima Y; Nakano H; Kamiyama R; Uehara T; Kirino Y; Sekiguchi A; Ihata A; Ohno S; Nagaoka S; Nakajima H
Arthritis Res Ther; 2018 Jan; 20(1):7. PubMed ID: 29325580
[TBL] [Abstract][Full Text] [Related]
18. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].
Wang PZ; Guan JL; Han XH
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):417-20. PubMed ID: 19031800
[TBL] [Abstract][Full Text] [Related]
19. [Interstitial lung diseases in polymyositis and dermatomyositis].
Marie I; Dominique S; Rémy-Jardin M; Hatron PY; Hachulla E
Rev Med Interne; 2001 Nov; 22(11):1083-96. PubMed ID: 11817120
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G
Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
